NL-OMON31945
Completed
Not Applicable
Research for markers of bone quality - CLAST study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Osteoporosis
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 100
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Postmenopausal women with a vertebral fracture and postmenopausal women without a vertebral fracture with high bone mineral density (T\-score \>\-1 S.D.)
Exclusion Criteria
- •Medication influencing osteoclast function and formation (Bisphosphonates, Hormone Replacement Therapy, Strontium Ranelate, Teriparatide, Raloxifen)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
study to assess the changes in bone health after changing from a TDF based regimen to Bicetegravir-Tenofovir Alafenamide-Emtricitavine based treatmentEUCTR2018-004499-36-ESConsorci Mar Parc de Salut de Barcelona60
Completed
Not Applicable
Assessment of bone related bio-markers in patients with rheumatoid arthritis treated with Certolizumab pegolrheumatoid arthritisJPRN-UMIN000029594Graduate School of Medicine, Osaka University Department of Respiratory Medicine and Clinical Immunology40
Recruiting
Not Applicable
Prostate cancer and bone healthHealth Condition 1: null- Prostate cancer patients who presents to KGMU for treatment will be enrolled in the study.CTRI/2017/08/009451King George Medical University80
Not yet recruiting
Not Applicable
Polycystic ovarian syndrome & Chronic PeriodontitisHealth Condition 1: R888- Abnormal findings in other body fluids and substancesHealth Condition 2: E282- Polycystic ovarian syndromeCTRI/2019/09/021214SERB DST
Completed
Phase 4
Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate CancerProstate CancerNCT00391690Novartis99